Novartis Pharmaceuticals Corporation
Time frame: 1 April 2023 - 31 March 2024Article ‘Count’ and ‘Share’ for Novartis Pharmaceuticals Corporation based on listed parameters only.
The articles listed below published by authors from Novartis Pharmaceuticals Corporation, organized by journal and article, represent the research output in Count and Share according to the parameters selected above.
Journal | Count | Share |
---|---|---|
American Journal of Respiratory and Critical Care Medicine |
1 | 0.10 |
Blood |
1 | 0.08 |
Circulation |
1 | 0.29 |
Clinical Infectious Diseases |
1 | 0.04 |
European Heart Journal |
2 | 0.24 |
Hepatology |
1 | 0.08 |
Journal of Clinical Oncology |
2 | 0.23 |
Journal of the American College of Cardiology |
4 | 0.60 |
Kidney International |
1 | 0.06 |
Nature Medicine |
1 | 0.13 |
Ophthalmology |
1 | 0.09 |
The Lancet |
1 | 0.08 |
The Lancet Neurology |
1 | 0.06 |
The Lancet Oncology |
1 | 0.10 |
The New England Journal of Medicine |
1 | 0.06 |
![Creative Commons License](https://i.creativecommons.org/l/by-nc-sa/4.0/80x15.png)
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.